Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance. Chandra A, Jahangiri A, Chen W, Nguyen AT, et al. Cancer Res 2020;80:1498-1511.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chandra A, Jahangiri A, Chen W, Nguyen AT, et al. Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance. Cancer Res 2020;80:1498-1511.
PMID: 32041837